The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Artificial Blood-Global Market Insights and Sales Trends 2025
Synopsis
Artificial blood, also called oxygen therapeutics or hemoglobin-based oxygen carriers, offer the promise of new life-saving medical treatments.
The global Artificial Blood market size is expected to reach US$ 6771.3 million by 2029, growing at a CAGR of 11.6% from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Blood in various end use industries. The expanding demands from the Hemoglobin-Based Oxygen Carriers (HBOCs) and Perflurocarbon Emulsions (PFCEs), are propelling Artificial Blood market. Human Blood, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Synthetic Blood segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Blood, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Blood market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Blood market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Blood sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Blood covered in this report include Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma and Alpha Therapeutic Corporation, etc.
The global Artificial Blood market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
Global Artificial Blood market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Blood market, Segment by Type:
Human Blood
Synthetic Blood
Animal Blood
Global Artificial Blood market, by Application
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perflurocarbon Emulsions (PFCEs)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Artificial Blood companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Artificial blood, also called oxygen therapeutics or hemoglobin-based oxygen carriers, offer the promise of new life-saving medical treatments.
The global Artificial Blood market size is expected to reach US$ 6771.3 million by 2029, growing at a CAGR of 11.6% from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Blood in various end use industries. The expanding demands from the Hemoglobin-Based Oxygen Carriers (HBOCs) and Perflurocarbon Emulsions (PFCEs), are propelling Artificial Blood market. Human Blood, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Synthetic Blood segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Blood, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Blood market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Blood market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Blood sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Blood covered in this report include Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma and Alpha Therapeutic Corporation, etc.
The global Artificial Blood market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
Global Artificial Blood market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Blood market, Segment by Type:
Human Blood
Synthetic Blood
Animal Blood
Global Artificial Blood market, by Application
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perflurocarbon Emulsions (PFCEs)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Artificial Blood companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Artificial Blood
1.1 Artificial Blood Market Overview
1.1.1 Artificial Blood Product Scope
1.1.2 Artificial Blood Market Status and Outlook
1.2 Global Artificial Blood Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Artificial Blood Market Size by Region (2018-2029)
1.4 Global Artificial Blood Historic Market Size by Region (2018-2023)
1.5 Global Artificial Blood Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Artificial Blood Market Size (2018-2029)
1.6.1 North America Artificial Blood Market Size (2018-2029)
1.6.2 Europe Artificial Blood Market Size (2018-2029)
1.6.3 Asia-Pacific Artificial Blood Market Size (2018-2029)
1.6.4 Latin America Artificial Blood Market Size (2018-2029)
1.6.5 Middle East & Africa Artificial Blood Market Size (2018-2029)
2 Artificial Blood Market by Type
2.1 Introduction
2.1.1 Human Blood
2.1.2 Synthetic Blood
2.1.3 Animal Blood
2.2 Global Artificial Blood Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Artificial Blood Historic Market Size by Type (2018-2023)
2.2.2 Global Artificial Blood Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Artificial Blood Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Artificial Blood Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Artificial Blood Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Artificial Blood Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Artificial Blood Revenue Breakdown by Type (2018-2029)
3 Artificial Blood Market Overview by Application
3.1 Introduction
3.1.1 Hemoglobin-Based Oxygen Carriers (HBOCs)
3.1.2 Perflurocarbon Emulsions (PFCEs)
3.2 Global Artificial Blood Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Artificial Blood Historic Market Size by Application (2018-2023)
3.2.2 Global Artificial Blood Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Artificial Blood Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Artificial Blood Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Artificial Blood Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Artificial Blood Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Artificial Blood Revenue Breakdown by Application (2018-2029)
4 Artificial Blood Competition Analysis by Players
4.1 Global Artificial Blood Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artificial Blood as of 2022)
4.3 Date of Key Players Enter into Artificial Blood Market
4.4 Global Top Players Artificial Blood Headquarters and Area Served
4.5 Key Players Artificial Blood Product Solution and Service
4.6 Competitive Status
4.6.1 Artificial Blood Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Dextro-Sang Corporation
5.1.1 Dextro-Sang Corporation Profile
5.1.2 Dextro-Sang Corporation Main Business
5.1.3 Dextro-Sang Corporation Artificial Blood Products, Services and Solutions
5.1.4 Dextro-Sang Corporation Artificial Blood Revenue (US$ Million) & (2018-2023)
5.1.5 Dextro-Sang Corporation Recent Developments
5.2 BioPure Corporation
5.2.1 BioPure Corporation Profile
5.2.2 BioPure Corporation Main Business
5.2.3 BioPure Corporation Artificial Blood Products, Services and Solutions
5.2.4 BioPure Corporation Artificial Blood Revenue (US$ Million) & (2018-2023)
5.2.5 BioPure Corporation Recent Developments
5.3 Sangart
5.3.1 Sangart Profile
5.3.2 Sangart Main Business
5.3.3 Sangart Artificial Blood Products, Services and Solutions
5.3.4 Sangart Artificial Blood Revenue (US$ Million) & (2018-2023)
5.3.5 Northfield Laboratories Recent Developments
5.4 Northfield Laboratories
5.4.1 Northfield Laboratories Profile
5.4.2 Northfield Laboratories Main Business
5.4.3 Northfield Laboratories Artificial Blood Products, Services and Solutions
5.4.4 Northfield Laboratories Artificial Blood Revenue (US$ Million) & (2018-2023)
5.4.5 Northfield Laboratories Recent Developments
5.5 Baxter International
5.5.1 Baxter International Profile
5.5.2 Baxter International Main Business
5.5.3 Baxter International Artificial Blood Products, Services and Solutions
5.5.4 Baxter International Artificial Blood Revenue (US$ Million) & (2018-2023)
5.5.5 Baxter International Recent Developments
5.6 Dentritech
5.6.1 Dentritech Profile
5.6.2 Dentritech Main Business
5.6.3 Dentritech Artificial Blood Products, Services and Solutions
5.6.4 Dentritech Artificial Blood Revenue (US$ Million) & (2018-2023)
5.6.5 Dentritech Recent Developments
5.7 FluorO2 Therapeutics
5.7.1 FluorO2 Therapeutics Profile
5.7.2 FluorO2 Therapeutics Main Business
5.7.3 FluorO2 Therapeutics Artificial Blood Products, Services and Solutions
5.7.4 FluorO2 Therapeutics Artificial Blood Revenue (US$ Million) & (2018-2023)
5.7.5 FluorO2 Therapeutics Recent Developments
5.8 Nuvox Pharma
5.8.1 Nuvox Pharma Profile
5.8.2 Nuvox Pharma Main Business
5.8.3 Nuvox Pharma Artificial Blood Products, Services and Solutions
5.8.4 Nuvox Pharma Artificial Blood Revenue (US$ Million) & (2018-2023)
5.8.5 Nuvox Pharma Recent Developments
5.9 Alpha Therapeutic Corporation
5.9.1 Alpha Therapeutic Corporation Profile
5.9.2 Alpha Therapeutic Corporation Main Business
5.9.3 Alpha Therapeutic Corporation Artificial Blood Products, Services and Solutions
5.9.4 Alpha Therapeutic Corporation Artificial Blood Revenue (US$ Million) & (2018-2023)
5.9.5 Alpha Therapeutic Corporation Recent Developments
5.10 HemoBioTech
5.10.1 HemoBioTech Profile
5.10.2 HemoBioTech Main Business
5.10.3 HemoBioTech Artificial Blood Products, Services and Solutions
5.10.4 HemoBioTech Artificial Blood Revenue (US$ Million) & (2018-2023)
5.10.5 HemoBioTech Recent Developments
6 North America
6.1 North America Artificial Blood Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Artificial Blood Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Artificial Blood Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Artificial Blood Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Artificial Blood Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Artificial Blood Market Dynamics
11.1 Artificial Blood Industry Trends
11.2 Artificial Blood Market Drivers
11.3 Artificial Blood Market Challenges
11.4 Artificial Blood Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
